Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report

Atypical hemolytic uremic syndrome (aHUS) is a subtype of thrombotic microangiopathy (TMA) characterized by a dysregulation of the alternative complement pathway. Here, we report a previously healthy 38-year-old woman in whom aHUS developed after a COVID-19 vaccine booster. One day after receipt of...

Descripción completa

Detalles Bibliográficos
Autores principales: Claes, Kathleen J., Geerts, Inge, Lemahieu, Wim, Wilmer, Alexander, Kuypers, Dirk R.J., Koshy, Priyanka, Ombelet, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the National Kidney Foundation, Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484133/
https://www.ncbi.nlm.nih.gov/pubmed/36342000
http://dx.doi.org/10.1053/j.ajkd.2022.07.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484133/
https://www.ncbi.nlm.nih.gov/pubmed/36342000
http://dx.doi.org/10.1053/j.ajkd.2022.07.012

Ejemplares similares